Download integrale PDF - Progetto Mondiale Asma - Ginasma

521. Larsson S, Svedmyr N, Thiringer G. Lack of bronchial
beta adrenoceptor resistance in asthmatics during longterm
treatment with terbutaline.
J Allergy Clin Immunol 1977; 59: 93-100.
522. Bengtsson B, Fagerstrom PO. Extrapulmonary effects of
terbutaline during prolonged administration.
Clin Pharmacol Ther 1982; 31: 726-32.
523. Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers
GW, Donohue JF. Dose response to ipratropium as a
nebulized solution in patients with chronic obstructive
pulmonary disease. A three-center study.
Am Rev Respir Dis 1989; 139: 1188-91.
524. Davis A, Vickerson F, Worsley G, Mindorff C, Kazim F,
Levison H. Determination of dose-response relationship
for nebulized ipratropium in asthmatic children.
J Pediatr 1984; 105: 1002-5.
525. Boner AL, Vallone G, De Stefano G. Effect of inhaled
ipratropium bromide on methacholine and exercise
provocation in asthmatic children.
Pediatr Pulmonol 1989; 6: 81-5.
526. Svenonius E, Arborelius M Jr, Wiberg R, Ekberg P.
Prevention of exercise-induced asthma by drugs inhaled
from metered aerosols. Allergy 1988; 43: 252-7.
527. Bratteby LE, Foucard T, Lonnerholm G. Combined
treatment with ipratropium bromide and beta-2adrenoceptor
agonists in childhood asthma.
Eur J Respir Dis 1986; 68: 239-47.
528. Greenough A, Yuksel B, Everett L, Price JF. Inhaled
ipratropium bromide and terbutaline in asthmatic
children. Respir Med 1993; 87: 111-4.
529. Groggins RC, Milner AD, Stokes GM. Bronchodilator
effects of clemastine, ipratropium bromide, and
salbutamol in preschool children with asthma.
Arch Dis Child 1981; 56: 342-4.
530. Duchame FM, Davis GM. Randomized controlled trial of
ipratropium bromide and frequent low doses of
salbutamol in the management of mild and moderate
acute pediatric asthma. J Pediatr 1998; 133: 479-85.
531. Everard ML, Bara A, Kurian M. Anti-cholinergic drugs for
wheeze in children under the age of two years.
Cochrane Database Syst Rev 2000; 2.
532. Beasley CR, Rafferty P, Holgate ST. Bronchoconstrictor
properties of preservatives in ipratropium bromide
(Atrovent) nebuliser solution.
Br Med J (Clin Res Ed) 1987; 294: 1197-8.
533. Mann JS, Howarth PH, Holgate ST. Bronchoconstriction
induced by ipratropium bromide in asthma: relation to
hypotonicity.
Br Med J (Clin Res Ed) 1984; 289: 469.
534. FitzGerald JM, Grunfeld A. Status asthmaticus. In:
Lichtenstein LM, Fauci AS, eds. Current therapy in
allergy, immunology, and rheumatology. 5th edition.
St. Louis, MO: Mosby; 1996. p. 63-7.
535. Beasley R, Miles J, Fishwick D, Leslie H. Management
of asthma in the hospital emergency department.
Br J Hosp Med 1996; 55: 253-7.
536. FitzGerald JM. Development and implementation of
asthma guidelines.
Can Respir J 1998; 5 Suppl A: 85- 8A.
537. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S,
FitzGerald JM. Risk factors for near-fatal asthma. A
case-control study in hospitalized patients with asthma.
Am J Respir Crit Care Med 1998; 157: 1804-9.
538. Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B,
Horwitz RI, et al. Risk of fatal and near-fatal asthma in
relation to inhaled corticosteroid use.
JAMA 1992; 268: 3462-4.
539. Suissa S, Blais L, Ernst P. Patterns of increasing betaagonist
use and the risk of fatal or near-fatal asthma.
Eur Respir J 1994; 7: 1602-9.
540. Joseph KS, Blais L, Ernst P, Suissa S. Increased
morbidity and mortality related to asthma among
asthmatic patients who use major tranquillisers.
BMJ 1996; 312: 79-82.
541. Geelhoed GC, Landau LI, Le Souef PN. Evaluation of
SaO2 as a predictor of outcome in 280 children
presenting with acute asthma.
Ann Emerg Med 1994; 23: 1236-41.
542. Reddel H, Ware S, Marks G, Salome C, Jenkins C,
Woolcock A. Differences between asthma exacerbations
and poor asthma control. Lancet 1999; 353: 364-9.
543. Turner MO, Taylor D, Bennett R, FitzGerald JM. A
randomized trial comparing peak expiratory flow and
symptom self-management plans for patients with
asthma attending a primary care clinic.
Am J Respir Crit Care Med 1998; 157: 540-6.
544. Turner MO, Gafni A, Swan D, FitzGerald JM. A review
and economic evaluation of bronchodilator delivery
methods in hospitalized patients.
Arch Intern Med 1996; 156: 2113-8.
545. Foresi A, Morelli MC, Catena E. Low-dose budesonide
with the addition of an increased dose during
exacerbations is effective in long-term asthma control.
On behalf of the Italian Study Group.
Chest 2000; 117: 440-6.
546. Findley LJ, Sahn SA. The value of chest
roentgenograms in acute asthma in adults.
Chest 1981; 80: 535-6.
PROGRAMMA DI TRATTAMENTO DELL’ASMA IN SEI PARTI 175